Clyde Yancy, Roxana Mehran, and Howard Herrmann discuss strategies for increasing clinical trial enrollment among women, including targeting disease phenotypes and sex-specific trials. Sponsored by ...
A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback